By Andrew Joseph, STAT
Looking for diseases in newborns’ DNA that could arise during adulthood is more ethically fraught than focusing on childhood conditions.
By Helen Branswell, STAT
Will the U.S. get a licensed dengue vaccine? Will Sanofi pocket a coveted prize?…
By Lewis S. Nelson, Jeanmarie Perrone
Reports that merely being in a room with fentanyl, a powerful opioid, or its analogues can poison you don't match the action and effects of these drugs.
The increase in early vaccination may be due to fresh memories of how bad last winter was, but other factors may also be at play.
By David Armstrong, Andrew Joseph, STAT
A Kentucky appeals court sided with STAT, upholding a ruling ordering the release of Purdue Pharma records about the marketing of the opioid OxyContin.
By Lev Facher, STAT
The apparent birth this month of the first genetically modified babies is “a lesson in the potential for human hubris to overtake us,” Dr. Francis Collins, the director of the National Institutes of Health.
By Ike Swetlitz, STAT
The Department of Health and Human Services asserted in a letter to the Drug Enforcement Administration that two chemicals in kratom should be classified as Schedule I substances, meaning that the chemicals have “a high potential for abuse” and that…
By Elizabeth Cooney, STAT
A new study examining how long black or white people survive after a heart attack concludes that it’s socioeconomic status, far more than race, that explains who fares better.
If Republicans prevail in just two races on Tuesday, the Senate’s ranks would suddenly include two former drug industry lobbyists and a pharma CEO.
By Meghana Keshavan, STAT
Scientists say the data show over and over that early diagnosis of genetic disorders not only saves lives, but can keep long-term health care costs down.
Support Provided By:
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
Additional Support Provided By: